GCTK - Company ID 0001506983
GlucoTrack, Inc. trades as GCTK. This page tracks GlucoTrack, Inc. through 456 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Over the last 5 fiscal years GlucoTrack, Inc.'s revenue grew from $59.77K to $208.00K, a compound annual growth rate of 28.3%. Net profit margin expanded from -884.4% to 1690.4% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-15 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-14 |
| Major company event | 8-K | 2026-05-14 |
| Major company event | 8-K | 2026-05-07 |
| EFFECT | - | 2026-04-30 |
| Major company event | 8-K | 2026-04-30 |
| Major company event | 8-K | 2026-04-30 |
The largest companies sharing GlucoTrack, Inc.'s SEC industry classification (surgical & medical instruments & apparatus).
In its latest fiscal year GlucoTrack, Inc. reported a net loss of $19.39M.